| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.
|
Nat Med
|
2005
|
6.77
|
|
2
|
Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection.
|
Am J Pathol
|
2003
|
4.67
|
|
3
|
Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study.
|
Lancet
|
2010
|
4.52
|
|
4
|
Effective post-exposure treatment of Ebola infection.
|
PLoS Pathog
|
2007
|
3.69
|
|
5
|
Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys.
|
Lancet
|
2003
|
3.57
|
|
6
|
Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia.
|
MBio
|
2014
|
3.49
|
|
7
|
Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event.
|
J Infect Dis
|
2003
|
3.33
|
|
8
|
Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment.
|
Lancet
|
2006
|
3.15
|
|
9
|
Comprehensive panel of real-time TaqMan polymerase chain reaction assays for detection and absolute quantification of filoviruses, arenaviruses, and New World hantaviruses.
|
Am J Trop Med Hyg
|
2010
|
2.92
|
|
10
|
Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus.
|
Proc Natl Acad Sci U S A
|
2003
|
2.82
|
|
11
|
Molecular Evidence of Sexual Transmission of Ebola Virus.
|
N Engl J Med
|
2015
|
2.71
|
|
12
|
Development of a new vaccine for the prevention of Lassa fever.
|
PLoS Med
|
2005
|
2.71
|
|
13
|
Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo.
|
Proc Natl Acad Sci U S A
|
2010
|
2.69
|
|
14
|
Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells.
|
Am J Pathol
|
2003
|
2.66
|
|
15
|
Recombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primates.
|
J Virol
|
2008
|
2.58
|
|
16
|
A broad-spectrum antiviral targeting entry of enveloped viruses.
|
Proc Natl Acad Sci U S A
|
2010
|
2.41
|
|
17
|
Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus.
|
J Virol
|
2009
|
2.41
|
|
18
|
Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox.
|
Proc Natl Acad Sci U S A
|
2004
|
2.36
|
|
19
|
Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses.
|
Vaccine
|
2008
|
2.33
|
|
20
|
Postexposure protection of guinea pigs against a lethal ebola virus challenge is conferred by RNA interference.
|
J Infect Dis
|
2006
|
2.19
|
|
21
|
Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates.
|
PLoS Pathog
|
2008
|
2.10
|
|
22
|
Marburg virus Angola infection of rhesus macaques: pathogenesis and treatment with recombinant nematode anticoagulant protein c2.
|
J Infect Dis
|
2007
|
2.09
|
|
23
|
The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a nonhuman primate model.
|
Proc Natl Acad Sci U S A
|
2004
|
1.85
|
|
24
|
Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine.
|
J Virol
|
2006
|
1.85
|
|
25
|
Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies.
|
Proc Natl Acad Sci U S A
|
2007
|
1.76
|
|
26
|
Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany.
|
J Infect Dis
|
2011
|
1.62
|
|
27
|
FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection.
|
Sci Transl Med
|
2013
|
1.62
|
|
28
|
Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae.
|
Arch Virol
|
2012
|
1.59
|
|
29
|
Depletion of peripheral blood T lymphocytes and NK cells during the course of ebola hemorrhagic Fever in cynomolgus macaques.
|
Viral Immunol
|
2004
|
1.55
|
|
30
|
Ebola virus: new insights into disease aetiopathology and possible therapeutic interventions.
|
Expert Rev Mol Med
|
2004
|
1.52
|
|
31
|
Pathologic findings associated with delayed death in nonhuman primates experimentally infected with Zaire Ebola virus.
|
J Infect Dis
|
2007
|
1.52
|
|
32
|
ST-246 antiviral efficacy in a nonhuman primate monkeypox model: determination of the minimal effective dose and human dose justification.
|
Antimicrob Agents Chemother
|
2009
|
1.45
|
|
33
|
In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent protein.
|
J Infect Dis
|
2007
|
1.43
|
|
34
|
Postexposure treatment of Marburg virus infection.
|
Emerg Infect Dis
|
2010
|
1.43
|
|
35
|
Cynomolgus macaque as an animal model for severe acute respiratory syndrome.
|
PLoS Med
|
2006
|
1.40
|
|
36
|
Comparative analysis of viral gene expression programs during poxvirus infection: a transcriptional map of the vaccinia and monkeypox genomes.
|
PLoS One
|
2008
|
1.37
|
|
37
|
Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates.
|
PLoS Negl Trop Dis
|
2012
|
1.32
|
|
38
|
Capacity building permitting comprehensive monitoring of a severe case of Lassa hemorrhagic fever in Sierra Leone with a positive outcome: case report.
|
Virol J
|
2011
|
1.29
|
|
39
|
Ebola virus genome plasticity as a marker of its passaging history: a comparison of in vitro passaging to non-human primate infection.
|
PLoS One
|
2012
|
1.28
|
|
40
|
The pathogenesis of Rift Valley fever virus in the mouse model.
|
Virology
|
2010
|
1.28
|
|
41
|
Interferon-β therapy prolongs survival in rhesus macaque models of Ebola and Marburg hemorrhagic fever.
|
J Infect Dis
|
2012
|
1.27
|
|
42
|
Evolution of ebola virus disease from exotic infection to global health priority, Liberia, mid-2014.
|
Emerg Infect Dis
|
2015
|
1.21
|
|
43
|
The temporal program of peripheral blood gene expression in the response of nonhuman primates to Ebola hemorrhagic fever.
|
Genome Biol
|
2007
|
1.20
|
|
44
|
Zaire Ebola virus entry into human dendritic cells is insensitive to cathepsin L inhibition.
|
Cell Microbiol
|
2009
|
1.16
|
|
45
|
Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae.
|
Arch Virol
|
2013
|
1.16
|
|
46
|
Lymphocyte death in a mouse model of Ebola virus infection.
|
J Infect Dis
|
2007
|
1.12
|
|
47
|
Real-time monitoring of cardiovascular function in rhesus macaques infected with Zaire ebolavirus.
|
J Infect Dis
|
2011
|
1.12
|
|
48
|
Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA.
|
Arch Virol
|
2013
|
1.10
|
|
49
|
Countermeasures to the bioterrorist threat of smallpox.
|
Curr Mol Med
|
2005
|
1.08
|
|
50
|
Inhibition of heat-shock protein 90 reduces Ebola virus replication.
|
Antiviral Res
|
2010
|
1.04
|
|
51
|
Development of a novel nonhuman primate model for Rift Valley fever.
|
J Virol
|
2011
|
0.99
|
|
52
|
Stunned silence: gene expression programs in human cells infected with monkeypox or vaccinia virus.
|
PLoS One
|
2011
|
0.98
|
|
53
|
Cellular immune response to Marburg virus infection in cynomolgus macaques.
|
Viral Immunol
|
2008
|
0.96
|
|
54
|
Therapeutics of Ebola hemorrhagic fever: whole-genome transcriptional analysis of successful disease mitigation.
|
J Infect Dis
|
2011
|
0.96
|
|
55
|
Evaluation of Lassa antiviral compound ST-193 in a guinea pig model.
|
Antiviral Res
|
2011
|
0.94
|
|
56
|
Potential vaccines and post-exposure treatments for filovirus infections.
|
Viruses
|
2012
|
0.94
|
|
57
|
The NIAID Integrated Research Facility at Frederick, Maryland: a unique international resource to facilitate medical countermeasure development for BSL-4 pathogens.
|
Pathog Dis
|
2014
|
0.93
|
|
58
|
Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever.
|
Virol J
|
2010
|
0.92
|
|
59
|
Aerosol exposure to Rift Valley fever virus causes earlier and more severe neuropathology in the murine model, which has important implications for therapeutic development.
|
PLoS Negl Trop Dis
|
2013
|
0.91
|
|
60
|
Evidence against an important role for infectivity-enhancing antibodies in Ebola virus infections.
|
Virology
|
2002
|
0.90
|
|
61
|
Development of Vaccinia reporter viruses for rapid, high content analysis of viral function at all stages of gene expression.
|
Antiviral Res
|
2011
|
0.90
|
|
62
|
Progression of pathogenic events in cynomolgus macaques infected with variola virus.
|
PLoS One
|
2011
|
0.87
|
|
63
|
Transcriptional profiling of the circulating immune response to lassa virus in an aerosol model of exposure.
|
PLoS Negl Trop Dis
|
2013
|
0.87
|
|
64
|
Ebola virus exploits a monocyte differentiation program to promote its entry.
|
J Virol
|
2013
|
0.86
|
|
65
|
Identification of a pyridopyrimidinone inhibitor of orthopoxviruses from a diversity-oriented synthesis library.
|
J Virol
|
2011
|
0.83
|
|
66
|
Ultrastructural study of Rift Valley fever virus in the mouse model.
|
Virology
|
2012
|
0.82
|
|
67
|
Lack of effect of lamivudine on Ebola virus replication.
|
Emerg Infect Dis
|
2015
|
0.82
|
|
68
|
In vitro inhibition of monkeypox virus production and spread by Interferon-β.
|
Virol J
|
2012
|
0.81
|
|
69
|
Genomic variability of monkeypox virus among humans, Democratic Republic of the Congo.
|
Emerg Infect Dis
|
2014
|
0.80
|
|
70
|
Lassa and Marburg viruses elicit distinct host transcriptional responses early after infection.
|
BMC Genomics
|
2014
|
0.79
|
|
71
|
Pathogen-host associations and predicted range shifts of human monkeypox in response to climate change in central Africa.
|
PLoS One
|
2013
|
0.77
|
|
72
|
Nonhuman transferrin receptor 1 is an efficient cell entry receptor for Ocozocoautla de Espinosa virus.
|
J Virol
|
2013
|
0.77
|
|
73
|
Probing the virus host interaction in high containment: an approach using pooled short hairpin RNA.
|
Assay Drug Dev Technol
|
2015
|
0.75
|
|
74
|
Systems kinomics for characterizing host responses to high-consequence pathogens at the NIH/NIAID Integrated Research Facility-Frederick.
|
Pathog Dis
|
2014
|
0.75
|